Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partnership
Strategic agreement secures access to essential oncology injectables for clinical trials as European shortages intensify.
Florida / New York
Ph: 561.316.3330
View the latest clinical trials, studies, data, and updates.
Strategic agreement secures access to essential oncology injectables for clinical trials as European shortages intensify.
Clinical Global Impression Data Showed Statistically Significant & Clinically Relevant Improvement in Pediatric PANS Patients.
Known as “XTRACT,” this prospective, multi-center, single-arm, post-market registry study will assess the clinical performance of the Rotarex™ Atherectomy System in the treatment of U.S. patients with PAD lesions.
“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.
Trial achieves positive results in the treatment of persistent atrial fibrillation.
In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330